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Quinolone antibiotics are clinically important drugs
that target bacterial DNA replication and chromo-
some segregation. Although the AcrAB-family efflux
pumps generally protect bacteria from such drugs,
the physiological role of these efflux systems and
their interplay with other cellular events are poorly
explored. Here, we report an intricate relationship
between antibiotic resistance and cell polarity in
the model bacterium Caulobacter crescentus. We
show that a polarity landmark protein, TipN, identi-
fied by virtue of its ability to direct flagellum place-
ment to the new cell pole, protects cells from toxic
misregulation of an AcrAB efflux pump through a
cis-encoded nalidixic acid-responsive transcrip-
tional repressor. Alongside the importance of polar-
ity in promoting the inheritance and activity of
virulence functions including motility, we can now
ascribe to it an additional role in drug resistance
that is distinct from classical efflux mechanisms.
INTRODUCTION
Resistance to antibiotics can come from multiple sources, for
example, target alteration, drug inactivation or its expulsion
from cells. The quinolone antibiotics (Heeb et al., 2011) nalidixic
acid (Nal) and ciprofloxacin (Cipro) target the type II topoiso-
merases DNA gyrase and topoisomerase IV. These enzymes
are required for DNA supercoiling and chromosome decatena-
tion, respectively, processes without which DNA replication,
and therefore cell division, cannot be completed. Both enzymes
break and rejoin double-stranded DNA strands (Morais Cabral
et al., 1997), and quinolones inhibit strand rejoining, but not
breakage. Therefore, quinolone-treated cells eventually die
from accumulated DNA double-strand breaks. Target alteration
mutations are common in quinolone-resistant bacteria (Jacoby,
2005) and often occur in a region of the GyrA subunit of gyrase,
or the ParC subunit of topoisomerase IV, known as the quinolone
resistance-determining region (QRDR) encompassing the active
site (Friedman et al., 2001; Yoshida et al., 1990). Two QRDR res-
idues (Ser83 and Asp87 in Escherichia coli GyrA) are frequentlyChemistry & Biology 21,mutated in clinical isolates (Yoshida et al., 1988) and result in
impaired quinolone binding (Barnard and Maxwell, 2001).
Quinolones are also substrates of AcrAB-TolC pumps, tripartite
efflux systems usually under control of tetracycline repressor
(TetR)-like transcriptional regulators (Ramos et al., 2005). The
pump genes are expressed when the drug or substrate dis-
lodges the repressor from the promoter, allowing pump tran-
scription and expulsion of the drug from the cells. Quinolone
resistance can be conferred by loss-of-function mutations in
such repressors (Wang et al., 2001), so pump genes are consti-
tutively derepressed, or as promoter-up mutations ablating
repressor binding.
Caulobacter crescentus (henceforth Caulobacter), a polarized
alpha-proteobacterium that is naturally resistant to Nal, coordi-
nates chromosome replication and segregation with asymmetric
division. The cell cycle culminates in the formation of two dissim-
ilar progenies with distinct polar structures and replicative ca-
pacities (Skerker and Laub, 2004). The swarmer cell has a single
flagellum and several pili at the old pole and is incapable of DNA
replication. By contrast the stalked cell is competent for DNA
replication and cell division and bears a stalk at the old pole.
The swarmer cell must differentiate into a stalked cell to enter
the DNA replication (S) phase. The chromosome replicates
only once per cell cycle, and completion of replication and segre-
gation (processes that require DNA gyrase and topoisomerase
IV) is tightly coordinated with cell division and polar differentia-
tion such that the asymmetric division cycle is repeated in every
generation. It remains unexplored whether quinolone resistance
is linked with such cell-cycle functions and/or morphogenesis.
The pole-determinant protein TipN was identified through its
role in assigning the flagellum assembly location via formation
of a ‘‘birth scar’’ at the cell division site (Huitema et al., 2006;
Lam et al., 2006). In the absence of TipN, the flagellum is assem-
bled at erroneous locations, with a concomitant reduction of
motility. TipN appears to play a role in chromosome segregation
through an interaction with ParAB-parS (Ptacin et al., 2010;
Schofield et al., 2010). Interestingly, transposon insertions in
tipN were only generated by electroporation (Huitema et al.,
2006) and not by intergeneric conjugation from an E. coli donor
strain counterselected by Nal (Christen et al., 2011; Huitema
et al., 2006), suggesting that tipN mutants are Nal sensitive.
This possible link prompted us to investigate whether Nal sensi-
tivity of DtipN was due to target alteration, drug modification, or
efflux. We identified an AcrAB-family efflux pump through a for-
ward genetic approach to restore Nal resistance toDtipN, but we657–665, May 22, 2014 ª2014 Elsevier Ltd All rights reserved 657
Figure 1. Nal Sensitivity of DtipN Is Independent of Gyrase A
(A) Growth of WT Caulobacter (NA1000), DtipN with empty vector, and
complemented DtipN on agar containing 20 mg/ml Nal after 3 days
at 30C.
(B) Growth inhibition assay of NA1000, DtipN, and complemented DtipN
with Nal.
(C) Growth inhibition assay of NA1000, DlexA, and DtipN with Nal or Cipro.
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658 Chemistry & Biology 21, 657–665, May 22, 2014 ª2014 Elsevierfound that it did not confer resistance by a classical efflux-medi-
ated mechanism. Instead, Nal-induced overexpression of the
pump was toxic to DtipN cells and mitigated by loss of the
pump. This previously unsuspected genetic interaction of a
polarity factor with an antibiotic efflux system unveils an unusual
mechanism of quinolone sensitivity that acts independently of
the classical effect on type II topoisomerases.
RESULTS AND DISCUSSION
Nal Sensitivity of DtipN Cells Is Not due to DNA Gyrase
Inhibition
Complementation experiments confirmed that a functional copy
of tipN is required to support colony formation on Nal-contain-
ing agar (20 mg/ml Nal) (Figure 1A) and efficient growth in broth
containing Nal, as determined by growth inhibition assay (Fig-
ure 1B). We also confirmed that growth on Nal of other polarity
mutants, either in genes downstream of tipN (tipF) or in parallel
pathways (podJ), was unaffected (Figure S1A available online).
To examine whether growth inhibition of DtipN was also
observed for another quinolone, and whether another Caulo-
bacter mutant (DlexA, a mutant that has the SOS response to
DNA damage constitutively turned on due to inactivation of
the LexA repressor) also displayed this pattern of antibiotic
sensitivity, we performed growth inhibition assays for Nal and
Cipro (Figure 1C). Although Cipro was active against all strains
at 50-fold lower concentrations than Nal, there was no differ-
ence in the Cipro sensitivity between wild-type (WT) and DtipN
cells, whereas DlexA cells were partially sensitized to both
antibiotics.
Because DtipN cells did not exhibit altered sensitivity to Cipro
compared with WT, it seemed possible that TipN affects Nal
sensitivity by a GyrA-independent mechanism. Indeed, the
QRDR of Caulobacter GyrA compared with that of Nal-sensitive
alpha-proteobacteria revealed a polymorphism at position 96
(Phe instead of Asp) of GyrA in Caulobacter not observed in
GyrA of the other genera, including Brucella melitensis, which
have Asp at the corresponding position (Figure S1B). Because
this position in the QRDR is known to affect quinolone binding
(Barnard and Maxwell, 2001), we hypothesized that it may be
responsible for the intrinsic Nal resistance of Caulobacter. To
test this hypothesis, we expressed WT Caulobacter gyrA, WT
Brucella melitensis gyrA, and Caulobacter gyrA(F96D) encoding
a point mutant with Asp in place of Phe at position 96, from a
vanillate (Van)-inducible promoter in WT and DtipN cells, and
then we measured Nal growth inhibition (Figure 1D). None of
these genes inhibited growth when overexpressed, and the
WT Caulobacter gyrA gene had no effect on Nal sensitivity,
whereas the B. melitensis gyrA slightly increased it. However,(D) Growth of NA1000 and DtipN carrying empty vector (pMT335), WT
Caulobacter gyrase A (gyrA-Cc), WTB. melitensis gyrase A (gyrA-Bm), or point
mutant Caulobacter gyrase A (gyrA-F96D), expressed as percentage of OD600
of untreated control culture of each strain, with 50 mMVan and/or 20 mg/ml Nal.
(E) Promoter activity of PCC3213 in NA1000 containing the four constructs used
in Figure 1D, in response to 20 mg/ml Nal, measured by b-galactosidase assay.
(F) Promoter activity of PCC3213 in NA1000 and DtipN in response to 20 mg/ml
Nal or 0.5 mg/ml Cipro.
See also Figures S1 and S2.
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Figure 2. Nal Resistance in DtipN Is Restored by Increased Produc-
tion of TipR
(A) Schematic diagram (to scale) of the locus identified by the transposon
screen and spontaneous mutant generation, with the positions of the trans-
poson insertion (himar1) and the point mutation (SNP) indicated.
(B) Growth inhibition assay of NA1000, DtipN, DtipN himar1::PtipR, and DtipN
SNP::PtipR with Nal.
(C) Activity of the acrA and tipR promoters (PacrA and PtipR, respectively) with
and without the SNP, ±20 mg/ml Nal, measured by b-galactosidase assay in
NA1000 (i) and SNP::PtipR (ii).
(D) Activity of the acrA and tipR promoters (PacrA and PtipR, respectively) with
and without the SNP, in NA1000 with or without overexpressed tipR (i), and in
DtipR ± 20 mg/ml Nal (ii).
See also Figure S3.
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with and without Van (Figure 1D).
Next, we tested whether Nal caused DNA damage in the pres-
ence of the F96Dmutation, using a reporter for the DNA damage
(SOS)-inducible promoter of CC_3213, one of the LexA-target
genes (da Rocha et al., 2008). Whereas the F96D-encoding allele
increased promoter activity in response to Nal, the other GyrA
variants did not (Figure 1E). This induction was similar to that
elicited by Cipro for this promoter (Figure 1F), suggesting that
converting GyrA F96 to D makes Nal as potent as Cipro inChemistry & Biology 21,causing DNA damage and thus inhibiting growth. Moreover,
we confirmed that DtipN cells were not more sensitive to DNA
damage than WT cells (Figure 1F) and that Nal did not normally
induce the SOS response in either strain (Figure 1F; Figure S2).
Thus, our results unexpectedly revealed an alternative mode of
growth inhibition by Nal that does not involve DNA damage.
TipR Overexpression Mitigates the Nal Sensitivity of
DtipN Cells
To investigate how Nal inhibits growth of DtipN cells, we sought
spontaneous mutants by enrichment culturing of DtipN cells in
broth containing Nal (20 mg/ml) until colony formation was
possible on Nal (20 mg/ml)-containing agar. Genome sequencing
of two such mutants showed that they had no alterations in
the DNA gyrase or topoisomerase IV genes. Interestingly, one
mutant encoded a transition (C/T, henceforth SNP::PtipR)
within the promoter region of two divergently oriented coding se-
quences (Figure 2A): CC_0808 (CCNA_00851), an acrA homolog
and apparently the first gene in an operon encoding an AcrAB-
like drug efflux pump, and CC_0809 (CCNA_00852) (named
here tipR, for tipN-suppressive regulator) encoding a TetR-like
transcription factor. Strikingly, this promoter region was also
targeted by random himar1-based transposon mutagenesis
(himar1::PtipR) of DtipN cells conducted in parallel with selection
for mutants that grew on Nal-containing agar (Figure 2A). We
backcrossed the himar1::PtipR and theSNP::PtipRmutation sepa-
rately into DtipN cells and observed that the resulting mutants
exhibited near WT resistance to Nal (<50 mg/ml) (Figure 2B;
Figure S3A).
Because this intergenic region presumably contained the
promoters for both the flanking genes, we tested whether the
SNP::PtipR mutation had altered the activity of PtipR or the diver-
gent acrAB2 promoter by constructing b-galactosidase pro-
moter-probe plasmids (PtipR-lacZ and PacrA-lacZ) and then
exposing cells containing these constructs to Nal (Figure 2C).
We observed that WT PacrA-lacZ was induced 4-fold by Nal
in WT (Figure 2Ci) or DtipN cells (Figure S3B). However,
SNP-PacrA-lacZ was no longer inducible by Nal and the activity
of SNP-PtipR-lacZ activity was strongly enhanced in all strains
(Figure 2C; Figures S3B and S3C). Basal and Nal-induced WT
PacrA activity was strongly diminished in the SNP::PtipR mutant
(Figure 2Cii), suggesting that the product of tipR represses PacrA
in trans. The himar1::PtipR mutation also had reduced relative in-
duction of PacrA-lacZ, albeit from a higher basal level (Fig-
ure S3C). Confirming the trans-effect of the SNP::PtipR mutation,
TipR overexpression diminished the induction of PacrA (Fig-
ure 2Di). Inactivation of the tipR gene (DtipR) had the opposite
effect (Figure 2Dii), derepressing basal promoter activity to the
level observed with Nal.
To confirm that TipR represses PacrA, we conducted chromatin
immunoprecipitation (ChIP) using antibodies to TipR followed by
quantitative PCR (qChIP). These experiments revealed a 10-fold
reduction in TipR occupancy at PacrA by Nal (20 mg/ml) in
both WT and DtipN cells (Figure 3A), despite no decrease in
TipR steady-state levels as determined by immunoblotting
(data not shown). Next, we conducted electrophoretic mobility
shift assays (EMSAs) with purified His6-TipR to confirm that
TipR binds PacrA directly and to test whether Nal affects bind-
ing in vitro (Figure 3B). We observed that formation of the657–665, May 22, 2014 ª2014 Elsevier Ltd All rights reserved 659
Figure 3. TipR Is a Nal-Responsive TetR-
Like Repressor of the acrA Promoter
(A) In vivo binding (qChIP) of endogenous TipR to
PacrA in NA1000, DtipN, and DtipR. Mid-log phase
cells of NA1000 and DtipN were incubated with or
without 20 mg/ml Nal before crosslinking treatment
and harvesting of chromatin. TipR-bound DNAwas
immunoprecipitated with polyclonal antibodies
against TipR and purified. TipR binding was calcu-
lated as the ratio of ChIP to input DNA for PacrA and
the control promoter PtacA. The graph shows the
data normalized to PtacA (PacrA ChIP/input)/(PtacA
ChIP/input) becauseweobservedbyChIP-seq that
Nal caused an increase in nonspecific TipR binding
over the whole genome and that in NA1000 PtacA is
not specifically bound by TipR (data not shown).
(B) In vitro binding (EMSA) of His6-TipR to a
biotin-labeled probe containing PacrA. His6-TipR
(50 nM) was incubated with the labeled probe
and with decreasing concentrations of Nal (100–
3.125 mg/ml). The arrow indicates the band shift of
the labeled probe induced by His6-TipR binding.
A representative image of three independent ex-
periments is shown.
(C) Quantification of the three EMSA experiments
performed as in (B). Data represent the normalized
intensity of the band corresponding to the shifted
probe, relative to the quantity of shifted probe in
the absence of Nal.
(D) Immunoblotting with specific antibodies for
TipR and FtsZ in NA1000, DtipN, DtipN SNP::PtipR,
and DtipN himar1::PtipR strains. A representative
image of three independent experiments is shown.
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50 mg/ml Nal (Figure 3C). Although the conditions used here do
not replicate the intracellular environment, this result indicates
that Nal directly interferes with the ability of TipR to bind DNA.
Returning to the Nal-sensitivity suppressor mutants, we per-
formed immunoblotting for TipR with the same antibody used
for qChIP. This revealed elevated TipR steady-state levels in
the SNP::PtipR and himar1::PtipR mutants relative to WT and
DtipN cells, whereas the loading control (FtsZ) was nearly un-
changed (Figure 3D). We conclude that TipR indeed acts as a
typical TetR-like repressor that is dislodged from the promoter
of its associated efflux pump upon perceiving a signal or ligand
and that suppression of DtipN Nal sensitivity is associated with
induction of this protein.
To quantify the in vivo dose response of Nal on TipR, we
measured PacrA-lacZ activity in WT and DtipN cells and found
that the induction to be maximal from 25 to 3 mg/ml Nal (see Fig-
ure 5D). By contrast, the promoter was highly active and no
longer inducible in DtipR cells even over a range of Nal concen-
trations (Figure S2D), indicating that TipR is the only regulator
controlling the induction of PacrA by Nal.
Opposite Effects of the AcrAB2 Efflux Pump on Nal
versus Cipro Resistance
Consistent with the SNP::PtipR and himar1::PtipR mutants, over-
expression of TipR from a high-copy plasmid was sufficient to
confer Nal resistance to DtipN cells, while also boosting that of
WT cells (Figure 4A). However, it seemed counterintuitive that
overproduction of this repressor should confer increased resis-660 Chemistry & Biology 21, 657–665, May 22, 2014 ª2014 Elseviertance to Nal, because it ought to repress expression of the efflux
pump and, according to classical models, increase drug sensi-
tivity due to diminished efflux (Ramos et al., 2005). Investigating
the effect of TipR overexpression further, we discovered that it
increased sensitivity to 1 and 0.5 mg/ml of Cipro compared
with control cells (Figure 4B). This suggests that the AcrAB2
efflux pump expels Cipro and that TipR overexpression causes
Cipro sensitivity presumably by reducing AcrAB2 expression.
To investigate whether the opposite effects of TipR on Nal and
Cipro sensitivity were due to inverse regulation of PacrA, we
measured TipR-dependent activity of PacrA-lacZ in response to
Nal, Cipro, or the nonquinolone antibiotic chloramphenicol (Fig-
ure 4C). Although Cipro increased promoter activity by 50%,
chloramphenicol did not affect it. Therefore, the structurally
simpler quinolone Nal is a far better inducer of the acrAB2 genes
than the more complex molecule Cipro. Because induction was
strongest with Nal and because the AcrAB2 efflux pump can
expel Cipro, we reasoned that Nal-dependent induction of
AcrAB2 should boost resistance to Cipro, whereas supplement-
ingwith Cipro should have no effect on resistance to Nal, and this
was indeed the case (Figure 4D). To confirm that the tipR-acrAB2
locus is responsible for this improvement of Cipro resistance in
the presence of Nal, we repeated the Cipro growth inhibition
assay for WT and DacrAB2-nodT with and without Nal (Fig-
ure 4E). The DacrAB2-nodT strain was sensitized to Cipro rela-
tive to WT, and the protective effect of Nal was lost. Therefore,
protection by Nal against Cipro is indeed mediated by the
AcrAB2 pump under control of TipR. With 20 mg/ml Nal, which
is nontoxic due to the endogenous Nal-resistant gyrase A ofLtd All rights reserved
Figure 4. AcrAB2 Is Controlled by TipR and
Mediates Cipro Resistance
(A) Nal growth inhibition assay of NA1000 and
DtipN with or without TipR overexpression.
(B) Cipro growth inhibition assay of NA1000with or
without TipR overexpression.
(C) Promoter activity of PacrA in NA1000 with
20 mg/ml Nal, 2 mg/ml Cipro, and 1 mg/ml chlor-
amphenicol.
(D) Growth inhibition assay of NA1000with Nal and
Cipro. Cultures being tested for growth in Nal were
supplemented or not with 0.5 mg/ml Cipro,
whereas cultures being tested for growth in Cipro
were supplemented or not with 20 mg/ml Nal.
These concentrations were selected because they
correspond to the highest concentrations that
did not inhibit growth of NA1000 relative to the
untreated control.
(E) Growth inhibition assay of NA1000 and
DacrAB2-nodT with Cipro supplemented or not
with 20 mg/ml Nal, expressed as percentage of
OD600 of control culture of each strain without
Cipro.
See also Figure S4.
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duced to sufficiently high levels to confer efflux-mediated resis-
tance to Cipro, which would otherwise kill the cells through DNA
damage (presumably because it can inhibit gyrase, whereas Nal
cannot).
We also analyzed the antibiotic resistance profile of DacrAB2-
nodT relative to WT for other classes of antibiotics by disk diffu-
sion assay (Figure S4) and observed that loss of this efflux pump
led to increased sensitivity to chloramphenicol, tetracycline, and
rifampicin. However, WT cells were already quite sensitive to
these antibiotics (based on the size of the inhibition zone), so
we cannot conclude that AcrAB2-NodT contributes significantly
to basal resistance against them.
Inverse Relationship between DtipN PacrA Expression
and Growth in Nal
To unravel the effect of the AcrAB2-NodT pump in DtipN, we
introduced the DacrAB2-nodT deletion into DtipN cells and
compared growth inhibition assays for Nal and Cipro (Figure 5A)
in DacrAB2-nodT and DtipN DacrAB2-nodT cells. In both cases,
the DacrAB2-nodT deletion increased sensitivity to Cipro (1 and
0.5 mg/ml) as well as to high Nal (100, 50, and 25 mg/ml), similarly
to the SNP::PtipR mutation in the NA1000 and DtipN back-
grounds (Figure S3A). However, the DacrAB2-nodT deletion
also increased resistance to low Nal in DtipN cells similarly to
the SNP::PtipR and himar1::PtipR mutants and the tipR-overex-Chemistry & Biology 21, 657–665, May 22, 2014pression strain (Figures 2B and 4A). This
confirmed that the AcrAB2-NodT efflux
pump is protective against Cipro but
is toxic for DtipN cells in the presence
of <25 mg/ml Nal, despite the similarity
of these two antibiotics.
Due to the endogenous Nal resistance
conferred by WT gyrase A, it was not
possible to infer from Figure 5A whetherthe DacrAB2-nodT mutation affected efflux of <25 mg/ml Nal.
We therefore re-examined whether the pump is competent
for Nal efflux by subverting the endogenous resistance using
gyrA(F96D) (Figure 5B). We compared the growth of WT and
DacrAB2-nodT strains carrying either WT gyrA or mutant
gyrA(F96D) and observed that neither the DacrAB2-nodT
deletion nor the gyrA(F96D) plasmid alone could alter resis-
tance to 2 mg/ml Nal or lower, but that the two together
made the cells strongly Nal sensitive. Therefore, the pump is
not normally required by WT to confer Nal resistance, because
the endogenous target (GyrA) is insensitive to it, but it is
required for growth in the presence of gyrA(F96D) and must
therefore be capable of Nal efflux. Similarly, DtipN cells
are not sensitized to Nal by the gyrase F96D mutation unless
the pump is also deleted, demonstrating that the pump is
still functional in the DtipN background (Figure 5C). However,
with the WT gyrA gene, the DtipN DacrAB2-nodT strain was
more resistant to low Nal than the DtipN single mutant. This
result eliminated the possibility that the AcrAB2 efflux
pump works less well in the absence of TipN, because then
the double mutant should only have achieved growth in
Nal less than or equal to the DtipN single mutant. Thus, the
AcrAB2 efflux pump is involved in quinolone resistance, but
in DtipN cells displays opposite effects on Nal and Cipro
resistance despite being capable of efflux of both these
antibiotics.ª2014 Elsevier Ltd All rights reserved 661
Figure 5. The AcrAB2 System Is Active for
Nal Efflux, but Its Overexpression Is Toxic
to DtipN
(A) Growth inhibition assay of NA1000, DtipN,
DacrAB2-nodT, and DtipN DacrAB2-nodT with
Nal or Cipro.
(B) Growth inhibition assay of NA1000 and
DacrAB2-nodT carrying either WT gyrA (gyrA-Cc)
or F96D point mutant gyrA (gyrA-F96D) with
low Nal.
(C) Growth inhibition assay of DtipN and DtipN
DacrAB2-nodT carrying either WT gyrA (gyrA-Cc)
or F96D point mutant gyrA (gyrA-F96D) with
low Nal.
(D) Promoter activity of PacrA in NA1000 and DtipN
with all concentrations of Nal previously used in
growth inhibition assays (100–0.125 mg/ml).
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concentrations of Nal (Figure 5D), we noted a striking negative
correlation between growth of DtipN cells in Nal and the activa-
tion of PacrA by Nal (compare Figure 5C to Figure 5D). Thus, we
conclude the DtipN strain is not sensitive to Nal per se, but
instead to induction of the AcrAB2-NodT efflux pump, with
growth inhibited at concentrations of Nal that induce maximal
expression of AcrAB2. This growth inhibition by overexpression
of the pump was specific to DtipN, because an identical pattern
of PacrA induction was observed in WT (Figure 5D), which was
capable of growth in Nal at all concentrations <20 mg/ml. Thus,
there is an underlying synthetic toxicity phenotype, unrelated
to the usual target of Nal but instead dependent on Nal as an
inducer of acrAB2-nodT gene expression combined with which
the lack of TipN is toxic to the cells.662 Chemistry & Biology 21, 657–665, May 22, 2014 ª2014 Elsevier Ltd All rights reservedInduction of the Complete AcrAB2-
NodT Pump, but Not of Pump
Activity, Is Required for DtipN
Synthetic Toxicity
To examine whether a particular compo-
nent of the efflux pump was responsible
for growth inhibition of DtipN by Nal, we
expressed acrA and acrB2 separately
and together from a Van-inducible pro-
moter in the DtipN and DtipN DacrAB2-
nodT strains with or without Van and Nal
at 2 mg/ml, a concentration that is inhibi-
tory for the single mutant but not for the
double mutant (Figure 6A). We did not
observe any growth inhibition on overex-
pression of these genes, suggesting that
neither AcrA nor AcrB2 is solely respon-
sible for the Nal-sensitivity phenotype.
We then investigated whether efflux
activity of this pump is required for the
synthetic toxicity by using the chemical
inhibitor phenylalanine arginine b-naph-
thylamide (PAbN) (Lomovskaya et al.,
2001; Renau et al., 1999). We had previ-
ously observed that loss of the pump
genes caused an increase in activity ofthe pump promoter, consistent with observations in E. coli
(Ruiz and Levy, 2014) and Salmonella enterica (Webber et al.,
2009), to a level intermediate between the basal activity and
Nal-induced or DtipR levels (Figure S5A). Taking increased PacrA
activity as a marker for loss of pump function, we tested the
effect of PAbN on this parameter. PacrA expression was in-
creased (2-fold) by 50 mM PAbN, although not to the level
observed in the DacrAB2-nodT strain, which was unchanged
by Nal or PAbN addition (Figure 6B). Higher PAbN concentra-
tions, as used in studies on E. coli (Ruiz and Levy, 2014), were
toxic to the cells (no growth observed during 20 hr growth inhibi-
tion assays) and did not produce any further increase in PacrA
expression above the level observed with 50 mM (data not
shown), so this concentration was the maximum used in subse-
quent experiments. Confirming its action as an efflux inhibitor,
Figure 6. AcrAB2-NodT Toxicity toDtipNCells Depends on the Pres-
ence of All Three Pump Components but Not on Pump Activity
(A) Growth of DtipN and DtipN DacrAB2-nodT carrying empty vector
(pMT335), acrA, acrB2, or acrAB2, expressed as percentage of OD600 of
untreated control culture of each strain, with 50 mM Van and/or 2 mg/ml Nal.
(B) Promoter activity of PacrA in NA1000 and DacrAB2-nodT with 20 mg/ml Nal
or 5, 25 and 50 mM PAbN.
(C) Promoter activity of PacrA in NA1000 and DtipN with 20 mg/ml Nal and/or
50 mM PAbN.
(D) PAbN growth inhibition assay of NA1000 and DtipN with or without
20 mg/ml Nal.
See also Figure S5.
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Chemistry & Biology 21,50 mM PAbN sensitized WT cells to Cipro, whereas DacrAB2-
nodT cells were sensitized to Cipro at even lower concentrations
(Figure S5B). We also observed that in both WT and DtipN cells,
addition of both Nal and PAbN increased PacrA expression to a
level intermediate between Nal or PAbN alone, similar to that
observed in the DacrAB2-nodT mutant where the pump is
absent (Figure 6C).
We then asked whether PAbN could ameliorate the growth in-
hibition of the DtipN strain in 20 mg/ml Nal, hypothesizing that if
the synthetic toxicity arises from induced pump activity, PAbN
should have a protective effect. However, we observed that
there was no improvement in growth of this strain when PAbN
was added relative to cells growing in Nal alone and that
50 mM PAbN even inhibited growth of DtipN in the absence of
Nal (Figure 6D). Surprisingly, 50 mM PAbN also inhibited growth
of WT cells grown with Nal. The reason for this is unclear, but
a partial inhibitory effect has similarly been observed in
S. enterica (Sa´nchez-Romero and Casadesu´s, 2014) and may
be due to pleiotropic effects of PAbN on other efflux pumps, or
even directly on the cell membrane (Lamers et al., 2013). There-
fore, although pump induction by Nal leads to synthetic toxicity
with DtipN, efflux activity of the pump does not seem to be
required.
A paradoxical situation therefore emerges from this result: why
does pump induction cause sensitivity to an antibiotic that the
pump can expel from the cells? The usual paradigm of bacterial
efflux pumps considers them to be beneficial to the cells in the
presence of antibiotics but neutral in their absence. One excep-
tion to this has been demonstrated in E. coli where a mutant
lacking the efflux system AcrEF (DacrEF) is intolerant of AcrA
overexpression (Lau and Zgurskaya, 2005), reminiscent of the
Caulobacter DtipN mutant. This work concluded that the toxic
effect of AcrA overexpression in DacrEFwas a nonspecific effect
due to overcrowding of the periplasm by AcrA being synthetic
lethal with loss of the proposed ‘‘cleaning’’ of the periplasm by
AcrEF. However, no such periplasmic ‘‘cleaning’’ function has
been proposed for TipN, so it is unlikely that a similar mechanism
is operating here.
Evidence is emerging for a role of AcrAB-family efflux pumps
in virulence for the pathogens S. enterica or Klebsiella pneumo-
niae, where knockout of acrAB genes leads to inhibition of viru-
lence (Padilla et al., 2010; Webber et al., 2009) and altered gene
expression (Webber et al., 2009), even in the absence of antibi-
otics. Hence, it is probable that they have physiological roles in
the cell separate from their antibiotic efflux activity. Work in
E. coli has suggested that cellular metabolites may also be sub-
strates of AcrAB efflux pumps and that the antibiotic-indepen-
dent phenotypic effects of loss of AcrAB function may be due
to dysregulation of intracellular metabolite flux or signaling
(Ruiz and Levy, 2014). It remains to be seen whether induction,
rather than loss, of an AcrAB efflux pump can also affect these
parameters.
SIGNIFICANCE
We present evidence that the Nal-sensitivity phenotype of
DtipN Caulobacter cells is not due to a classical target alter-
ation mechanism, because the gyrase A and topoisomerase
IV coding sequences were unaltered. Furthermore, there is657–665, May 22, 2014 ª2014 Elsevier Ltd All rights reserved 663
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enzyme in the DtipN mutant or for any involvement of the
known secondary effects of TipN on chromosome segrega-
tion, because wewere able to restore Nal resistance without
improving the chromosome segregation defect character-
ized by synthetic lethality with the DpopZ mutation (Ebers-
bach et al., 2008; data not shown). Neither is it due to a defect
in antibiotic efflux, because we were able to improve—not
decrease—resistance of DtipN by deleting the quinolone-
responsive efflux pump acrAB2-nodT. The growth inhibition
observed upon Nal-dependent induction of acrAB2-nodT in
CaulobacterDtipN suggests that altering levels of this efflux
pump deregulates cell growth in a TipN-dependent manner,
raising the intriguing possibility that induction or potentia-
tion of such efflux pumps can be disadvantageous to bacte-
rial pathogens, potentially an alternative strategy against
multidrug-resistant bacteria. Our study underlines the
2-fold importance of polarity factors as drug targets. In the
case of TipN, not only is the protein critical for efficient
motility (paramount to virulence in pathogens) but also it
protects from AcrAB2-NodT toxicity induced by Nal. We
speculate that drugs targeting polarity factors, especially
polarity factors in pathogenic genera (Cowles et al., 2013;
Davis and Waldor, 2013; Strahl and Hamoen, 2012), could
be used to enhance efficacy of quinolones or other drugs
expelled by Acr-family pumps as they become less effi-
cient in eradicating life-threatening infections by bacterial
pathogens.
EXPERIMENTAL PROCEDURES
Growth Conditions
The C. crescentus and E. coli strains were grown in peptone-yeast extract
(PYE) at 30C and Luria broth at 37C, respectively, with appropriate antibi-
otics. Electroporations, conjugations from E. coli to Caulobacter, and general-
ized transduction with FCr30 bacteriophage were performed as described
previously (Ely, 1991). Nal, Cipro, and PAbN stock solutions were prepared
at 100 mg/ml in water, 2 mg/ml in 0.1 M HCl, and 100 mM in DMSO, respec-
tively. For experiments involving Cipro and PAbN, the vehicle was added to the
negative control cultures. Plasmid and strain constructions are described in
the Supplemental Information.
Growth Inhibition Assays
Caulobacter strains were grown to stationary phase, culture density (optical
density 600 [OD600]) was measured, and the starter cultures were diluted to
a final density of 106 cells/ml into PYE containing the antibiotic to be tested
along with other antibiotic selection markers for plasmids (and 50 mM Van to
induce gene expression from pMT335 derivatives, where appropriate). Cul-
tures were grown for 20 hr at 30C (at which point both WT and DtipN strains
reach stationary phase), and then the OD600 was measured. Data are ex-
pressed throughout as a percentage of the OD600 of a control culture of
each strain, including plasmid selection markers and Van where necessary
but without the antibiotic being tested. All graphs show mean ± SEM from
three independent experiments.
b-galactosidase Assays and Immunoblotting
b-galactosidase assays were performed by the method of Miller (1972) at
30C, and data are presented as mean ± SEM from three independent exper-
iments throughout. His6-TipR was overexpressed from pET28-tipR in E. coli
Rosetta and purified under native conditions by nickel-nitrilotriacetic acid
chelate chromatography. Purified His6-TipR protein was used to immunize
rabbits (Josman). Cell extracts were prepared frommidexponential phase cul-
tures normalized to culture density, electrophoresed in 15% SDS-polyacryl-664 Chemistry & Biology 21, 657–665, May 22, 2014 ª2014 Elsevieramide gels, and then the proteins were transferred to polyvinylidene fluoride
membranes. Anti-TipR and anti-FtsZ (Radhakrishnan et al., 2010) were diluted
to 1/10,000.
ChIP
ChIP experiments followed by quantitative PCR were performed as described
previously (Radhakrishnan et al., 2008). For qChIP, the primers p0808_
qchip_f1 and p0808_qchip_r1 were used to amplify 150 base pairs (bp) of
the PacrA/PtipR region, whereas primers tacA chip F and tacA chip R were
used to amplify 255 bp of the tacA promoter. Quantitative PCR was performed
in triplicate for each sample, on samples from four independent experiments.
Data are expressed as ChIP to input ratios with the PacrA ratio normalized to
that of PtacA in each condition (so that absence of specific binding corresponds
to a value of 1), expressed as mean ± SEM (n = 4).
EMSA
A 50-biotin labeled probe (296 bp) was generated by PCR with primers
809_emsa_b_50 and 809_emsa_b_30 and purified by agarose gel electropho-
resis. Binding reactions were performed in 10 mM Tris-HCl (pH 8.0), 100 mM
NaCl, and 5% glycerol buffer, with 50 nM His6-TipR, 2 mg of poly(dI:dC), and
2 fmol of labeled probe, for 30 min at room temperature. Reactions were
electrophoresed in a nondenaturing 5.5% Tris-borate-EDTA-acrylamide gel,
transferred to positively charged nitrocellulose membrane, and immobilized
by UV-crosslinking. Probes were detected by hybridization with streptavidin-
horseradish peroxidase using the Chemiluminescent Detection Module
(Thermo Scientific) according to the manufacturer’s instructions. Quantifica-
tion of bands was performed with Image Lab 4.1 software (Bio-Rad) using
an automated workflow, and quantified data are presented as mean ± SEM
of three independent experiments.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and four tables can be found with this article online at http://dx.
doi.org/10.1016/j.chembiol.2014.02.018.
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